| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
|
Nat Med
|
2004
|
4.69
|
|
2
|
A genetically defined model for human ovarian cancer.
|
Cancer Res
|
2004
|
3.02
|
|
3
|
Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium.
|
Am J Physiol Cell Physiol
|
2006
|
1.59
|
|
4
|
Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment.
|
Cell Cycle
|
2010
|
1.48
|
|
5
|
Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
|
Cancer Res
|
2005
|
1.39
|
|
6
|
The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
|
Cancer Res
|
2003
|
1.26
|
|
7
|
The origin of ovarian carcinomas: a developmental view.
|
Gynecol Oncol
|
2008
|
1.26
|
|
8
|
Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells.
|
J Clin Endocrinol Metab
|
2004
|
1.25
|
|
9
|
Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of beta1 integrin.
|
Mol Cancer Res
|
2009
|
1.17
|
|
10
|
Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells.
|
Endocrinology
|
2006
|
1.12
|
|
11
|
Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
|
Differentiation
|
2008
|
1.10
|
|
12
|
Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression.
|
Int J Cancer
|
2007
|
1.10
|
|
13
|
Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.
|
Cancer Res
|
2006
|
1.10
|
|
14
|
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer.
|
J Cell Sci
|
2008
|
1.09
|
|
15
|
Role of PELP1/MNAR signaling in ovarian tumorigenesis.
|
Cancer Res
|
2008
|
1.05
|
|
16
|
Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.
|
Exp Cell Res
|
2004
|
1.04
|
|
17
|
The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
|
Differentiation
|
2007
|
1.02
|
|
18
|
Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both post-translational and transcriptional levels through a cyclic AMP/protein kinase A pathway.
|
J Biol Chem
|
2005
|
0.98
|
|
19
|
TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
|
PLoS One
|
2012
|
0.97
|
|
20
|
Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells.
|
Endocr Relat Cancer
|
2005
|
0.96
|
|
21
|
Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
|
Cancer Res
|
2007
|
0.96
|
|
22
|
EGF-induced EMT and invasiveness in serous borderline ovarian tumor cells: a possible step in the transition to low-grade serous carcinoma cells?
|
PLoS One
|
2012
|
0.95
|
|
23
|
Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines.
|
Mol Cancer Res
|
2006
|
0.95
|
|
24
|
Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary.
|
J Clin Endocrinol Metab
|
2006
|
0.94
|
|
25
|
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
|
Oncogene
|
2002
|
0.93
|
|
26
|
Normal ovarian surface epithelium.
|
Cancer Treat Res
|
2002
|
0.93
|
|
27
|
Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead.
|
Adv Exp Med Biol
|
2008
|
0.92
|
|
28
|
Ovarian surface epithelium: family history and early events in ovarian cancer.
|
Reprod Biol Endocrinol
|
2003
|
0.92
|
|
29
|
An improved assay to quantitate the invasiveness of cells in modified Boyden chambers.
|
In Vitro Cell Dev Biol Anim
|
2007
|
0.92
|
|
30
|
Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells.
|
J Clin Endocrinol Metab
|
2002
|
0.92
|
|
31
|
In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
|
Gynecol Oncol
|
2005
|
0.90
|
|
32
|
Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer.
|
Mol Cell Proteomics
|
2004
|
0.89
|
|
33
|
HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
|
Reprod Sci
|
2007
|
0.88
|
|
34
|
The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas.
|
Int J Cancer
|
2008
|
0.86
|
|
35
|
Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.
|
Gynecol Oncol
|
2005
|
0.86
|
|
36
|
Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation.
|
J Clin Endocrinol Metab
|
2004
|
0.85
|
|
37
|
Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer.
|
Int J Gynecol Cancer
|
2010
|
0.85
|
|
38
|
Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.
|
Endocr Relat Cancer
|
2006
|
0.85
|
|
39
|
Epithelio-mesenchymal transition in a neoplastic ovarian epithelial hybrid cell line.
|
Differentiation
|
2004
|
0.84
|
|
40
|
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.
|
Int J Cancer
|
2014
|
0.84
|
|
41
|
Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium.
|
Reprod Biol Endocrinol
|
2003
|
0.84
|
|
42
|
Effects of epidermal growth factor/hydrocortisone on the growth and differentiation of human ovarian surface epithelium.
|
J Soc Gynecol Investig
|
2004
|
0.83
|
|
43
|
Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents.
|
J Biomed Opt
|
2002
|
0.83
|
|
44
|
Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.
|
Gynecol Oncol
|
2004
|
0.83
|
|
45
|
Caspase-1zeta, a new splice variant of the caspase-1 gene.
|
Genomics
|
2004
|
0.83
|
|
46
|
HOX cofactors expression and regulation in the human ovary.
|
Reprod Biol Endocrinol
|
2008
|
0.82
|
|
47
|
Effects of growth differentiation factor 9 on cell cycle regulators and ERK42/44 in human granulosa cell proliferation.
|
Am J Physiol Endocrinol Metab
|
2009
|
0.82
|
|
48
|
Cell type- and stage-specific changes in HOXA7 protein expression in human ovarian folliculogenesis: possible role of GDF-9.
|
Differentiation
|
2006
|
0.81
|
|
49
|
Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
|
Clin Cancer Res
|
2004
|
0.81
|
|
50
|
Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
|
Endocr Relat Cancer
|
2006
|
0.80
|
|
51
|
Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells.
|
J Clin Endocrinol Metab
|
2004
|
0.80
|
|
52
|
SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells.
|
Gynecol Oncol
|
2008
|
0.80
|
|
53
|
Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion.
|
In Vitro Cell Dev Biol Anim
|
2003
|
0.80
|
|
54
|
Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.
|
Gynecol Oncol
|
2002
|
0.80
|
|
55
|
Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion.
|
Endocrine
|
2007
|
0.79
|
|
56
|
Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis.
|
Cancer Res
|
2005
|
0.78
|
|
57
|
Adenosine triphosphate activates mitogen-activated protein kinase in pre-neoplastic and neoplastic ovarian surface epithelial cells.
|
Biol Reprod
|
2003
|
0.77
|
|
58
|
HOXA4 protein levels and localization in the aorta and in human abdominal aortic aneurysms.
|
BMC Physiol
|
2011
|
0.75
|
|
59
|
Phosphatidylinositol 3-kinase-dependent, MEK- independent proliferation in response to CaR activation.
|
Am J Physiol Cell Physiol
|
2002
|
0.75
|
|
60
|
Re: "Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma".
|
Gynecol Oncol
|
2005
|
0.75
|
|
61
|
Re: Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.
|
J Natl Cancer Inst
|
2002
|
0.75
|
|
62
|
4-HPR modulates gene expression in ovarian cells.
|
Int J Cancer
|
2006
|
0.75
|